Canadian Centre on Substance Use and Addiction Evidence. Engagement. Impact.
Canadian Centre on Substance Use and Addiction

Canadian Drug Summaries provide the most recent statistics about substance use across our country and include information on trends, consequences and outcomes of substance use. These summaries help reduce harm for Canadians by providing information that supports evidence-informed decisions. Researchers collect national data from many sources and the summaries synthesize the results.

The most recent published drug summaries are below.

Alcohol

Cannabis

Opioids

Prescription drugs

Cocaine​

  • Cocaine​ (publication date, 2022)

Methamphetamin​e

Other Drugs​

Our Experts

Samantha King, PhD
Research and Policy Analyst
Get in touch for media requests or speaking engagements

Featured Resource

""
Report | 2022

3-4 Methylenedioxy-methamphetamine (MDMA, Ecstasy or Molly) (Canadian Drug Summary)

Summarizes data on the use of 3-4 methylenedioxy-methamphetamine (MDMA, ecstasy or Molly), including the harms, effects and legal status. MDMA is one of the most frequently identified controlled substances in illegal drugs seized by Canadian law enforcement agencies. In Canada, the prevalence of us…

Learn More about 3-4 Methylenedioxy-methamphetamine (MDMA, Ecstasy or Molly) (Canadian Drug Summary)

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.